Landiolol (Rapibloc)
- Status:
- Do Not Prescribe (DNP)
- Decision Date:
- August 2022
Comments
Supraventricular tachycardia and for the rapid control of ventricular
rate in patients with atrial fibrillation or atrial flutter in perioperative,
postoperative, or other circumstances where short-term control of the
ventricular rate with a short acting agent is desirable. search again